Clinical Trials Logo

Nasolabial Fold Correction clinical trials

View clinical trials related to Nasolabial Fold Correction.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04971876 Completed - Clinical trials for Midface Volume Deficit

Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler

Start date: October 27, 2020
Phase: N/A
Study type: Interventional

Evaluation of the safety and performance of the investigational device in its three concentrations for cheek and lips augmentation and correction of the nasolabial folds, assuming that the performance of the product will be demonstrated based on the responder rates observed compared to baseline.

NCT ID: NCT02991040 Completed - Clinical trials for Nasolabial Fold Correction

Study to Evaluate Safety and Efficacy of Revanesse® Ultra + vs Revanesse® Ultra for Correction of NLF

Start date: August 2016
Phase: N/A
Study type: Interventional

A Multicenter, Double-Blind, Randomized, Split-Face Study to Evaluate the Safety and Efficacy of Revanesse® Ultra + (with Lidocaine) versus Revanesse® Ultra for the Correction of Nasolabial Folds to compare the safety and efficacy profiles of Revanesse® Ultra + (with lidocaine, hereafter referred to as Revanesse Ultra +) to Revanesse Ultra for subjects undergoing correction of nasolabial folds (NLFs)

NCT ID: NCT02987205 Completed - Clinical trials for Nasolabial Fold Correction

Multicenter Double-Blind Randomized Split-Face Study to Evaluate Revanesse® Ultra vs Restylane® for Correction of NLF

Start date: May 2015
Phase: N/A
Study type: Interventional

A randomized, multicenter, double blind, split-face study in subjects seeking NLF correction. Subjects were treated with Revanesse Ultra in the NLF on one side of the face and Restylane in the NLF on the other side of the face. The side of the face for each product was randomly assigned. The investigator performing the evaluations and the subject were blinded to the treatment; injections of the study product were performed by an unblinded injecting investigator.

NCT ID: NCT02984878 Completed - Clinical trials for Nasolabial Fold Correction

Multicenter Study to Evaluate the Safety and Efficacy of Revanesse® Ultra Retreatment

Retreatment
Start date: November 2015
Phase: N/A
Study type: Interventional

To compare improvement with retreatment for all subjects undergoing correction of nasolabial folds (NLFs) in the initial SYM2014-02 study, who were retreated with Revanesse Ultra at Visit 6/Week 24 and to determine the safety of repeat injections of Revanesse Ultra. The retreatment phase was optional.